Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cephalexin Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 8/20 | 0.98 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.98 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.98 |
| ▸ | SLC15A2 | Q16348 | 3/20 | 0.98 |
| ▸ | HPGD | P15428 | 3/20 | 0.98 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.98 |
| ▸ | BLM | P54132 | 2/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.98 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.98 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.98 |
| ▸ | HTR2B | P41595 | 1/20 | 0.98 |
| ▸ | MEN1 | O00255 | 5/20 | 0.83 |
| ▸ | LMNA | P02545 | 2/20 | 0.83 |
| ▸ | ESR1 | P03372 | 1/20 | 0.83 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.83 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.83 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cephalexin Anhydrous SCHEMBL2353794 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL21962879 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL27943595 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL2353787 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL3002253 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL582342 | 0.99 | HSD17B10 (0.98) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL4928314 | 0.99 | HSD17B10 (0.98) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL27742537 | 0.99 | HSD17B10 (0.98) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL4928321 | 0.99 | HSD17B10 (0.98) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL10713860 | 0.99 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1930 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118782166-B | Method for rapidly predicting catalytic degradation rate of organic pollutants in peroxymonosulfate non-radical degradation system | 广东工业大学 | 2025-03-18 | — | — | CN | claimed |
| CN-115941232-B | Efficient anonymous single sign-on system and method based on key verification certificate | 福州大学 | 2025-01-17 | — | — | CN | claimed |
| CN-118847131-A | Fe-Co synergic double-doped bismuth-cobalt-Fe-based perovskite catalyst, and preparation method and application thereof | 广东工业大学 | 2024-10-29 | — | — | CN | claimed |
| CN-118782166-A | Method for rapidly predicting catalytic degradation rate of organic pollutants in peroxymonosulfate non-radical degradation system | 广东工业大学 | 2024-10-15 | — | — | CN | claimed |
| CN-117354169-A | System vulnerability distribution analysis method based on quasi-array theory | 西安理工大学 | 2024-01-05 | — | — | CN | claimed |
| CN-116502102-A | Self-research intelligent product operation system and method for cloud service | 深圳市伊登软件有限公司 | 2023-07-28 | — | — | CN | claimed |
| US-20230233575-A1 | HYDRATE ACCELERATOR, HYDRATE AND PREPARATION METHOD THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2023-07-27 | — | — | US | claimed |
| CN-108694123-B | Regression testing method, computer readable storage medium and terminal equipment | 中国平安人寿保险股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-114615338-B | Micro-service deployment method and device based on layer sharing in edge environment | 河海大学 | 2023-07-18 | — | — | CN | claimed |
| EP-4148033-A1 | HYDRATE ACCELERATOR, HYDRATE AND PREPARATION METHOD THEREFOR | China Petroleum & Chemical Corporation (CN) | 2023-03-15 | — | — | EP | claimed |
| EP-0528941-A1 | PROCESS FOR PREPARING CEPHALEXIN MONOHYDRATE | BIOCRAFT LABORATORIES, Inc. (US) | 1993-03-03 | — | — | EP | claimed |
| US-5142043-A | PROCESS FOR PREPARING CEPHALEXIN MONOHYDRATE | BIOCRAFT LABORATORIES, INC. (US) | 1992-08-25 | — | — | US | claimed |
| WO-1991017166-A1 | PROCESS FOR PREPARING CEPHALEXIN MONOHYDRATE | BIOCRAFT LABORATORIES, INC. (US) | 1991-11-14 | — | — | WO | claimed |
| US-5034522-A | Silating, acylation, basification and solvent extraction | BIOCRAFT LABORATORIES, INC. (US) | 1991-07-23 | — | — | US | claimed |
| US-4775751-A | Process for cephalexin hydrochloride alcoholates | ELI LILLY & COMPANY (US) | 1988-10-04 | — | — | US | claimed |
| US-4625021-A | High yield process for preparing beta-lactam antibiotics having a high purity degree | ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.P.A. (IT) | 1986-11-25 | — | — | US | claimed |
| EP-0169995-A2 | A high yield process for preparing beta-lactam antibiotics having a high purity degree | IBI- Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. (IT) | 1986-02-05 | — | — | EP | claimed |
| US-4486411-A | SYNERGISTIC MIXTURES WITH BETA-LACTAM ANTIBIOTICS | PFIZER INC. (US) | 1984-12-04 | — | — | US | claimed |
| EP-0003329-B1 | CEPHALEXIN-AMIDE COMPLEX, PROCESS FOR ITS PRODUCTION AND USE IN CEPHALEXIN-MONOHYDRATE PRODUCTION | BIOCHEMIE Gesellschaft m.b.H. (AT) | 1981-09-23 | — | — | EP | claimed |
| EP-0003329-A1 | Cephalexin-amide complex, process for its production and use in cephalexin-monohydrate production | BIOCHEMIE Gesellschaft m.b.H. (AT) | 1979-08-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230233575-A1 | HYDRATE ACCELERATOR, HYDRATE AND PREPARATION METHOD THEREOF | POLR2A, POLA1, POLR1E | HSD17B10 1347/4885MAPT 4287/4885ALDH1A1 1184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.